| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |